DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

MRI Homepage

Researchers develop MR technique to predict and prevent pregnancy complications Tracking water molecules to assess placenta health

Mayo Clinic expert emphasizes safety demands of interventional MR procedures Ideal solution is a dedicated iMR site

Community practices not abiding by breast cancer screening guidelines for MR High breast density isn't enough

Expert makes the case for patient access to radiology reports Patients want a more active role in their care

Top 10 trends and takeaways from RSNA 2017 Are radiologists going the way of the dodo bird? Of course not / Yes, yes they are

GE debuts new flexible, blanket-like MR coils at RSNA Improves patient comfort during whole body exams

Siemens unveils its GOKnee3D MR application at RSNA Cuts knee MR exam times in half

Siemens unveils two new intraoperative multi-modality therapy suites at RSNA The nexaris Angio-MR-CT and nexaris Angio-CT

MR machine rented to scan single terrorist at Guantánamo doesn't work Liquid helium dissipated for unknown reasons

Riccardo Lattanzi National Academy of Engineering selects young MR researcher for prestigious frontiers of engineering symposium

Sectra DoseTrack is equipped with a
new functionality that allows it to
receive messages from non-ionizing
imaging modalities, such as MR

Sectra announces MR and ultrasound monitoring capabilities for DoseTrack

by John Fischer , Staff Reporter
CHICAGO — Clinicians using Sectra DoseTrack will soon be able to analyze dosage data from additional imaging systems thanks to a new functionality.

The Sweden-based medical imaging IT company has programmed the next version of DoseTrack to receive and store messages in its database on dosage from non-ionizing imaging modalities, such as MR and ultrasound, thereby introducing new capabilities, such as gadolinium tracking, for enhancing patient care, safety and workflow.

Story Continues Below Advertisement

CT, MRI, NM, SPECT/CT, PET & PET/CT service, refurbished systems and parts

Accelerate your ROI with our Black Diamond Certified refurbished systems. One year warranty - ISO 13485 Certified - FDA registered - Over 65k parts in inventory



Until now, DoseTrack could retrieve and store information from ionizing sources, such as CT, but was unable to do the same with non-ionizing systems. A DoseTrack solution with the integrated feature was on display at the 2017 Radiological Society of North America (RSNA) annual conference.

“The product was initially designed to capture and analyze radiation delivered to patients,” Ian Judd, product manager at Sectra, told HCB News. “It was a natural progression in terms of functionality to next cater to non-ionizing modalities such as MR and US. Many customers are starting to use appropriateness criteria and vetting and justification of ionizing procedures. One of the natural effects of these changes in ordering methodology will lead to a shift in the case mix for each organization. A system like DoseTrack is able to spot these trends as orders are moved away from ionizing techniques or higher-dose techniques under certain circumstances, to help the customer monitor this process.”

Retention of gadolinium-based contrast agents (GBCAs) can cause serious repercussions, including nephrogenic systemic fibrosis, an incurable and potentially life-threatening disease. Research also indicates that deposits of gadolinium may accumulate in the brain, with the FDA currently investigating this risk.

Being able to track agents like gadolinium will enable health care professionals to identify trends and make changes in protocols throughout facilities to better protect patients.

Other enhancements to DoseTrack include a new dashboard, and enhanced workflow in nuclear medicine environments through the gathering of nuclear medicine isotope data electronically rather than manually, thereby improving image record and analytics capabilities of users.

The new version will also enable customers to see full imaging records across all modalities and departments including cardiology in a single view for the first time, ensuring greater comprehension of patient information which can be provided to referring clinicians and other key users in hospitals. With proper access controls and information governance permission, wider views on regional and national scales can also be achieved for further avoidance of unnecessary radiation and administration.

“Monitoring the use of contrast has obvious cost benefits to see if the amount ordered and used is optimal,” said Judd. “The important use case in terms of gadolinium is to provide customers with the ability to capture and monitor the use of this contrast to give clear alerts of any patients who may be at risk from multiple uses of the agent.”

The new version is set for release in the spring of 2018.

MRI Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED